Moderna norovirus vaccine on hold over case of Guillain-Barré
A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological disorder. The phase 3 study is evaluating the candidate, dubbed mRNA-1403, across two norovirus seasons. The trial is already fully enrolled in the Northern Hemisphere—with the first patient dosed last September—and Moderna … Read more